In the BioHarmony Drug Report Database

"Preview" Icon

Busulfan

Busulfex, Myleran, Busilvex (busulfan) is a small molecule pharmaceutical. Busulfan was first approved as Busulfex on 1982-01-01. It is used to treat bcr-abl positive chronic myelogenous leukemia, polycythemia vera, and primary myelofibrosis in the USA. It has been approved in Europe to treat hematopoietic stem cell transplantation.

 

Trade Name

 

Busilvex
 

Common Name

 

busulfan
 

ChEMBL ID

 

CHEMBL820
 

Indication

 

bcr-abl positive chronic myelogenous leukemia, hematopoietic stem cell transplantation, polycythemia vera, primary myelofibrosis
 

Drug Class

 

Antineoplastics, alkylating agents (methanesulfonate derivatives)

Image (chem structure or protein)

Busulfan structure rendering